Literature DB >> 15147523

Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats.

Paul J Tolentino1, Anuradha Waghray, Kevin K W Wang, Ronald L Hayes.   

Abstract

Tissue-type transglutaminase (TG-2) has been implicated in neurodegenerative diseases. In this study, induction of TG-2 was studied in rats following transient middle cerebral artery occlusion. Alterations in 2,3,5-triphenylterazolium chloride staining revealed maximum infarction 3 days after injury. Measurement of mRNA transcript levels by real-time PCR analysis showed both forms of TG-2 mRNA peaking on day 5 after injury in ipsilateral cortex, with greater induction of the full-length TG-2 (TG-L) transcript than the truncated form of the TG-2 (TG-S) transcript. However, in the ipsilateral hippocampus, peak induction of both forms of TG-2 mRNA peaked 1 day after injury and to a lesser extent than observed in the ipsilateral cortex. Western blot analysis demonstrated that TG-L protein expression progressively increased from 1 to 7 days after ischemia, with greater expression in cortex than hippocampus (525 +/- 10% vs. 196 +/- 8% of control, respectively). However, expression of TG-S was not detected. These results demonstrate that increased TG-2 mRNA and protein expression occurs in a delayed fashion following ischemic injury. The temporal profile of TG-2 induction after ischemia was similar to that observed after traumatic brain injury (previously described), suggesting a similar role of TG-2 in both pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147523     DOI: 10.1111/j.1471-4159.2004.02436.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

3.  Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.

Authors:  Laura Yunes-Medina; Julianne Feola; Gail V W Johnson
Journal:  Neuroreport       Date:  2017-12-13       Impact factor: 1.837

Review 4.  Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block.

Authors:  Manuela Basso; Rajiv R Ratan
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-10       Impact factor: 6.200

Review 5.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 6.  Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.

Authors:  Kajal Kanchan; Mónika Fuxreiter; László Fésüs
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

7.  Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.

Authors:  Ayako Miura; Yuki Kambe; Kazuhiko Inoue; Hideki Tatsukawa; Takashi Kurihara; Martin Griffin; Soichi Kojima; Atsuro Miyata
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

8.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.

Authors:  Anthony J Filiano; Craig D C Bailey; Janusz Tucholski; Soner Gundemir; Gail V W Johnson
Journal:  FASEB J       Date:  2008-03-28       Impact factor: 5.191

10.  Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.

Authors:  Laura Yunes-Medina; Alex Paciorkowski; Yan Nuzbrokh; Gail V W Johnson
Journal:  Mol Cell Neurosci       Date:  2017-11-29       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.